

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.26841872 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.98290801 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80750428 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.71747142 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.71747142 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.71422142 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.53612410 |
| 8 | negative T cell selection (GO:0043383) | 4.43685909 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.29040691 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.12015519 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.11289247 |
| 12 | positive T cell selection (GO:0043368) | 4.06383400 |
| 13 | nucleobase biosynthetic process (GO:0046112) | 4.02435131 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.00738153 |
| 15 | purine nucleobase biosynthetic process (GO:0009113) | 3.96866619 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93642197 |
| 17 | maturation of SSU-rRNA (GO:0030490) | 3.93104187 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 3.83728743 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.83728743 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81928919 |
| 21 | response to interleukin-15 (GO:0070672) | 3.75371828 |
| 22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.64151089 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54453377 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.53640786 |
| 25 | T cell selection (GO:0045058) | 3.49271473 |
| 26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.48713527 |
| 27 | activated T cell proliferation (GO:0050798) | 3.43058251 |
| 28 | protein targeting to ER (GO:0045047) | 3.42847032 |
| 29 | cytidine metabolic process (GO:0046087) | 3.42653104 |
| 30 | cytidine catabolic process (GO:0006216) | 3.42653104 |
| 31 | cytidine deamination (GO:0009972) | 3.42653104 |
| 32 | cotranslational protein targeting to membrane (GO:0006613) | 3.42327382 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 3.41241830 |
| 34 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.40454140 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39180260 |
| 36 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.37746222 |
| 37 | ribosome assembly (GO:0042255) | 3.36743093 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.35912711 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.35912711 |
| 40 | ribosomal large subunit biogenesis (GO:0042273) | 3.35552489 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.34991841 |
| 42 | viral transcription (GO:0019083) | 3.33580854 |
| 43 | translational termination (GO:0006415) | 3.33230886 |
| 44 | positive regulation of granulocyte differentiation (GO:0030854) | 3.31906707 |
| 45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.31327324 |
| 46 | thymic T cell selection (GO:0045061) | 3.30085098 |
| 47 | proteasome assembly (GO:0043248) | 3.29724215 |
| 48 | ribosome biogenesis (GO:0042254) | 3.28068280 |
| 49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.27687242 |
| 50 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26168971 |
| 51 | protein localization to endoplasmic reticulum (GO:0070972) | 3.26052843 |
| 52 | translational initiation (GO:0006413) | 3.24945803 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.23683343 |
| 54 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.21434055 |
| 55 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.21372873 |
| 56 | DNA strand elongation (GO:0022616) | 3.21002941 |
| 57 | DNA deamination (GO:0045006) | 3.20770085 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20206476 |
| 59 | cullin deneddylation (GO:0010388) | 3.19585474 |
| 60 | mitotic nuclear envelope disassembly (GO:0007077) | 3.19311860 |
| 61 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.19133538 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.19133538 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.18834971 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.18639392 |
| 65 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.18639392 |
| 66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.18639392 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.15719699 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15389887 |
| 69 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.14781675 |
| 70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.13753488 |
| 71 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.13753488 |
| 72 | mitotic metaphase plate congression (GO:0007080) | 3.13041824 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.10581472 |
| 74 | translation (GO:0006412) | 3.10292513 |
| 75 | nuclear pore organization (GO:0006999) | 3.10033468 |
| 76 | translational elongation (GO:0006414) | 3.09812730 |
| 77 | IMP biosynthetic process (GO:0006188) | 3.08931594 |
| 78 | positive regulation of defense response to virus by host (GO:0002230) | 3.08717816 |
| 79 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.07627688 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.07115580 |
| 81 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.06769534 |
| 82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06177114 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 3.05879081 |
| 84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.05226497 |
| 85 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.03977155 |
| 86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03180008 |
| 87 | regulation of translation in response to stress (GO:0043555) | 3.02520158 |
| 88 | protein deneddylation (GO:0000338) | 3.01545563 |
| 89 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00757427 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00391034 |
| 91 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98624629 |
| 92 | mast cell activation (GO:0045576) | 2.98522804 |
| 93 | positive regulation of ligase activity (GO:0051351) | 2.97891351 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 2.97226226 |
| 95 | GDP-mannose metabolic process (GO:0019673) | 2.96258702 |
| 96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.95373551 |
| 97 | DNA replication initiation (GO:0006270) | 2.94809304 |
| 98 | rRNA modification (GO:0000154) | 2.92977123 |
| 99 | nuclear envelope disassembly (GO:0051081) | 2.91638996 |
| 100 | membrane disassembly (GO:0030397) | 2.91638996 |
| 101 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.90798973 |
| 102 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90310459 |
| 103 | rRNA processing (GO:0006364) | 2.89268207 |
| 104 | DNA replication checkpoint (GO:0000076) | 2.88947530 |
| 105 | 7-methylguanosine mRNA capping (GO:0006370) | 2.88287934 |
| 106 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.87602868 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.87082198 |
| 108 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87082198 |
| 109 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85828372 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 2.85748236 |
| 111 | positive regulation of cell cycle arrest (GO:0071158) | 2.81926057 |
| 112 | transcription from RNA polymerase I promoter (GO:0006360) | 2.81288444 |
| 113 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.80403419 |
| 114 | RNA capping (GO:0036260) | 2.80170747 |
| 115 | 7-methylguanosine RNA capping (GO:0009452) | 2.80170747 |
| 116 | regulation of germinal center formation (GO:0002634) | 2.79559489 |
| 117 | cell cycle G1/S phase transition (GO:0044843) | 2.78663537 |
| 118 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.78663537 |
| 119 | telomere maintenance via recombination (GO:0000722) | 2.78460615 |
| 120 | rRNA metabolic process (GO:0016072) | 2.78449642 |
| 121 | termination of RNA polymerase I transcription (GO:0006363) | 2.78246135 |
| 122 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.78223866 |
| 123 | negative regulation of interleukin-1 production (GO:0032692) | 2.77768729 |
| 124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77494556 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.76734079 |
| 126 | adaptation of signaling pathway (GO:0023058) | 2.75896384 |
| 127 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75761644 |
| 128 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.75489568 |
| 129 | positive regulation of tolerance induction (GO:0002645) | 2.75269927 |
| 130 | regulation of gene silencing by RNA (GO:0060966) | 2.75099883 |
| 131 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.75099883 |
| 132 | regulation of gene silencing by miRNA (GO:0060964) | 2.75099883 |
| 133 | T cell migration (GO:0072678) | 2.74698278 |
| 134 | neutrophil activation involved in immune response (GO:0002283) | 2.74272469 |
| 135 | viral life cycle (GO:0019058) | 2.73806580 |
| 136 | tolerance induction (GO:0002507) | 2.72652187 |
| 137 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.71978883 |
| 138 | telomere maintenance via telomere lengthening (GO:0010833) | 2.70490297 |
| 139 | regulation of ligase activity (GO:0051340) | 2.67684193 |
| 140 | protein retention in ER lumen (GO:0006621) | 2.67662260 |
| 141 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.66947164 |
| 142 | regulation of tolerance induction (GO:0002643) | 2.65739519 |
| 143 | cellular extravasation (GO:0045123) | 2.65514006 |
| 144 | spliceosomal snRNP assembly (GO:0000387) | 2.64658684 |
| 145 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.64605862 |
| 146 | actin nucleation (GO:0045010) | 2.64224296 |
| 147 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.64208462 |
| 148 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.64064398 |
| 149 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.63870421 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63636024 |
| 151 | nuclear pore complex assembly (GO:0051292) | 2.63125009 |
| 152 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63043366 |
| 153 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63043366 |
| 154 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.63007274 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.61515758 |
| 156 | detection of other organism (GO:0098543) | 2.61398599 |
| 157 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60880337 |
| 158 | detection of bacterium (GO:0016045) | 2.60848021 |
| 159 | regulation of antigen processing and presentation (GO:0002577) | 2.60649914 |
| 160 | cellular protein complex disassembly (GO:0043624) | 2.60590674 |
| 161 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59684337 |
| 162 | neutrophil activation (GO:0042119) | 2.58988475 |
| 163 | mast cell activation involved in immune response (GO:0002279) | 2.58972675 |
| 164 | mast cell degranulation (GO:0043303) | 2.58972675 |
| 165 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.58825224 |
| 166 | blastocyst development (GO:0001824) | 2.58623894 |
| 167 | metaphase plate congression (GO:0051310) | 2.58284707 |
| 168 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.57831804 |
| 169 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.56777926 |
| 170 | viral mRNA export from host cell nucleus (GO:0046784) | 2.55210016 |
| 171 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.54228269 |
| 172 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.54228269 |
| 173 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.53134942 |
| 174 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52896260 |
| 175 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52896260 |
| 176 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.52852946 |
| 177 | cellular component biogenesis (GO:0044085) | 2.52437324 |
| 178 | cellular response to ethanol (GO:0071361) | 2.52312108 |
| 179 | tRNA aminoacylation for protein translation (GO:0006418) | 2.51921214 |
| 180 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49947072 |
| 181 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.49136697 |
| 182 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.47900631 |
| 183 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.47789799 |
| 184 | myeloid cell activation involved in immune response (GO:0002275) | 2.47484792 |
| 185 | leukocyte degranulation (GO:0043299) | 2.47364910 |
| 186 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.46013206 |
| 187 | leukocyte aggregation (GO:0070486) | 2.45958591 |
| 188 | granulocyte activation (GO:0036230) | 2.45846549 |
| 189 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.45734194 |
| 190 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.44874975 |
| 191 | response to interferon-beta (GO:0035456) | 2.44380453 |
| 192 | interferon-gamma production (GO:0032609) | 2.44320409 |
| 193 | regulation of cell killing (GO:0031341) | 2.43928833 |
| 194 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.41885862 |
| 195 | cellular response to type I interferon (GO:0071357) | 2.40723383 |
| 196 | type I interferon signaling pathway (GO:0060337) | 2.40723383 |
| 197 | regulation of mast cell activation (GO:0033003) | 2.40283225 |
| 198 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.39615768 |
| 199 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.38766595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20640768 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.75294329 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.49259813 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.03300574 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02404073 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57278359 |
| 7 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.34681656 |
| 8 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.23105324 |
| 9 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17712479 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11005502 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.09115526 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97391694 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.88961119 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.85192371 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85033980 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69367996 |
| 17 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.69314784 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.66740716 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.53330571 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.44511014 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36914406 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.36694562 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.36348460 |
| 24 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.36234072 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31074802 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.25471036 |
| 27 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23562054 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.23480665 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18954187 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18029260 |
| 31 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.18011842 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15795886 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11845280 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11330312 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11310294 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.11306463 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07589040 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06509556 |
| 39 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06501372 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06138059 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06058184 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02690897 |
| 43 | * GATA3_26560356_Chip-Seq_TH2_Human | 2.01257298 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94251966 |
| 45 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.92573187 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.88726960 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.85393215 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82511194 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80598570 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80525847 |
| 51 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.73693193 |
| 52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73139597 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72093806 |
| 54 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70072728 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.69212812 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67098544 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65628642 |
| 58 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62830192 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62467805 |
| 60 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.61703300 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61643570 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59704606 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59576179 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58757745 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.58212501 |
| 66 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57952257 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56032728 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.55912718 |
| 69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.54123725 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53445765 |
| 71 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52605445 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52237062 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51166448 |
| 74 | * MYB_26560356_Chip-Seq_TH1_Human | 1.50484611 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.50152447 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49971282 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48102121 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47743235 |
| 79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42427479 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41409611 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40358937 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39569276 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39403965 |
| 84 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38764467 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37239793 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36664241 |
| 87 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34715188 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34652544 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34014626 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33483567 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32940217 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30420587 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29718948 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28607932 |
| 95 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28117182 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28114934 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27983926 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27115757 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25638015 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23204940 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22658171 |
| 102 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21239076 |
| 103 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20763716 |
| 104 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20158832 |
| 105 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19261160 |
| 106 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19261160 |
| 107 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19261160 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19091262 |
| 109 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18089482 |
| 110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17431223 |
| 111 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16973907 |
| 112 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14427388 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13661435 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13351585 |
| 115 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12235783 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11380395 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10043946 |
| 118 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.09542364 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09468946 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08856891 |
| 121 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08073529 |
| 122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07574825 |
| 123 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07156859 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04643978 |
| 125 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02272362 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01776385 |
| 127 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00985195 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00635199 |
| 129 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00433086 |
| 130 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00378398 |
| 131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99899501 |
| 132 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98164653 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 0.98038631 |
| 134 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97118208 |
| 135 | MYC_22102868_ChIP-Seq_BL_Human | 0.96659020 |
| 136 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96053909 |
| 137 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.95910173 |
| 138 | MAF_26560356_Chip-Seq_TH2_Human | 0.95484304 |
| 139 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95333615 |
| 140 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95065873 |
| 141 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95029898 |
| 142 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94738998 |
| 143 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94667868 |
| 144 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94455658 |
| 145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94436110 |
| 146 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94352173 |
| 147 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94189249 |
| 148 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93815060 |
| 149 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93746350 |
| 150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93311575 |
| 151 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92493745 |
| 152 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91682548 |
| 153 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91540365 |
| 154 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.90424622 |
| 155 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89847166 |
| 156 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89383187 |
| 157 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89330211 |
| 158 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87993070 |
| 159 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87380953 |
| 160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87377071 |
| 161 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86863972 |
| 162 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86715263 |
| 163 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86015888 |
| 164 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85356427 |
| 165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85342644 |
| 166 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85268339 |
| 167 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84443966 |
| 168 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84386889 |
| 169 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83798584 |
| 170 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81487643 |
| 171 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80256682 |
| 172 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79735877 |
| 173 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79311856 |
| 174 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79055630 |
| 175 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78703297 |
| 176 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78693489 |
| 177 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.78621596 |
| 178 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78455011 |
| 179 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.78307628 |
| 180 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77885555 |
| 181 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77846716 |
| 182 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77270867 |
| 183 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75738614 |
| 184 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75157220 |
| 185 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73041587 |
| 186 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72487400 |
| 187 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72420642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.19516841 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.48603912 |
| 3 | MP0003436_decreased_susceptibility_to | 3.07012957 |
| 4 | MP0001800_abnormal_humoral_immune | 2.71569613 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.69037435 |
| 6 | MP0003077_abnormal_cell_cycle | 2.64048383 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.64030477 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.55428583 |
| 9 | MP0003123_paternal_imprinting | 2.52255361 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.47527848 |
| 11 | MP0002723_abnormal_immune_serum | 2.44093437 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.39883870 |
| 13 | MP0001790_abnormal_immune_system | 2.36168852 |
| 14 | MP0005387_immune_system_phenotype | 2.36168852 |
| 15 | MP0003303_peritoneal_inflammation | 2.27473167 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.27169445 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.25276001 |
| 18 | MP0005025_abnormal_response_to | 2.24145861 |
| 19 | MP0001819_abnormal_immune_cell | 2.23472925 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.22761676 |
| 21 | MP0002419_abnormal_innate_immunity | 2.13926453 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.13071072 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.01745514 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.01098489 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 2.00562013 |
| 26 | MP0003786_premature_aging | 2.00326015 |
| 27 | MP0008058_abnormal_DNA_repair | 2.00253700 |
| 28 | MP0006054_spinal_hemorrhage | 1.98652735 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.95986653 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.92008048 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.91135350 |
| 32 | MP0008057_abnormal_DNA_replication | 1.86319110 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.80819351 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.78114617 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.76673679 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.76267368 |
| 37 | MP0000716_abnormal_immune_system | 1.73290997 |
| 38 | MP0006082_CNS_inflammation | 1.70088201 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.69044925 |
| 40 | MP0001730_embryonic_growth_arrest | 1.64010781 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.62908543 |
| 42 | MP0003941_abnormal_skin_development | 1.61754688 |
| 43 | MP0002405_respiratory_system_inflammati | 1.56678896 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.55436013 |
| 45 | MP0005023_abnormal_wound_healing | 1.53223998 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.53086098 |
| 47 | MP0005503_abnormal_tendon_morphology | 1.49114678 |
| 48 | MP0003866_abnormal_defecation | 1.48102881 |
| 49 | MP0003186_abnormal_redox_activity | 1.47734118 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.47609998 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.46216188 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.45560645 |
| 53 | MP0001542_abnormal_bone_strength | 1.45295340 |
| 54 | MP0000604_amyloidosis | 1.44602792 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.40338123 |
| 56 | MP0005310_abnormal_salivary_gland | 1.38025386 |
| 57 | MP0001672_abnormal_embryogenesis/_devel | 1.35973821 |
| 58 | MP0005380_embryogenesis_phenotype | 1.35973821 |
| 59 | MP0009764_decreased_sensitivity_to | 1.35114180 |
| 60 | MP0001697_abnormal_embryo_size | 1.34034744 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.33919837 |
| 62 | MP0003880_abnormal_central_pattern | 1.33080291 |
| 63 | MP0002006_tumorigenesis | 1.32335833 |
| 64 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32046819 |
| 65 | MP0003984_embryonic_growth_retardation | 1.31030408 |
| 66 | MP0003718_maternal_effect | 1.29482659 |
| 67 | MP0008469_abnormal_protein_level | 1.28182351 |
| 68 | MP0002088_abnormal_embryonic_growth/wei | 1.27369693 |
| 69 | MP0005275_abnormal_skin_tensile | 1.26723880 |
| 70 | MP0004272_abnormal_basement_membrane | 1.26459057 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.26413511 |
| 72 | MP0003121_genomic_imprinting | 1.25201422 |
| 73 | MP0000490_abnormal_crypts_of | 1.25122353 |
| 74 | MP0002086_abnormal_extraembryonic_tissu | 1.23336928 |
| 75 | MP0004197_abnormal_fetal_growth/weight/ | 1.22145004 |
| 76 | MP0002080_prenatal_lethality | 1.20752431 |
| 77 | MP0002102_abnormal_ear_morphology | 1.20613049 |
| 78 | MP0004947_skin_inflammation | 1.19582005 |
| 79 | MP0004147_increased_porphyrin_level | 1.17781355 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.17560062 |
| 81 | MP0009745_abnormal_behavioral_response | 1.15150404 |
| 82 | MP0003119_abnormal_digestive_system | 1.13374246 |
| 83 | MP0001968_abnormal_touch/_nociception | 1.11937912 |
| 84 | MP0000858_altered_metastatic_potential | 1.10668956 |
| 85 | MP0002009_preneoplasia | 1.10171382 |
| 86 | MP0010030_abnormal_orbit_morphology | 1.09891935 |
| 87 | MP0003075_altered_response_to | 1.08129346 |
| 88 | MP0010307_abnormal_tumor_latency | 1.07969280 |
| 89 | MP0003690_abnormal_glial_cell | 1.06993157 |
| 90 | MP0001853_heart_inflammation | 1.05478708 |
| 91 | MP0002064_seizures | 1.05273110 |
| 92 | MP0009278_abnormal_bone_marrow | 1.04122319 |
| 93 | MP0002272_abnormal_nervous_system | 1.03631790 |
| 94 | MP0003787_abnormal_imprinting | 1.03082607 |
| 95 | MP0002876_abnormal_thyroid_physiology | 1.02510360 |
| 96 | MP0005257_abnormal_intraocular_pressure | 1.02414068 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 1.02273117 |
| 98 | MP0000313_abnormal_cell_death | 1.01963175 |
| 99 | MP0003635_abnormal_synaptic_transmissio | 1.01617000 |
| 100 | MP0002084_abnormal_developmental_patter | 1.01100439 |
| 101 | MP0003283_abnormal_digestive_organ | 1.00284063 |
| 102 | MP0008877_abnormal_DNA_methylation | 1.00158981 |
| 103 | MP0001243_abnormal_dermal_layer | 0.99287516 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.98783224 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.98217809 |
| 106 | MP0001486_abnormal_startle_reflex | 0.98079277 |
| 107 | MP0004142_abnormal_muscle_tone | 0.97293237 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.96377428 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.96377428 |
| 110 | MP0002085_abnormal_embryonic_tissue | 0.95630029 |
| 111 | MP0009785_altered_susceptibility_to | 0.95083423 |
| 112 | MP0002060_abnormal_skin_morphology | 0.95054397 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.94324091 |
| 114 | MP0000358_abnormal_cell_content/ | 0.93800212 |
| 115 | MP0003045_fibrosis | 0.93787001 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93180838 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.92694753 |
| 118 | MP0004859_abnormal_synaptic_plasticity | 0.91260300 |
| 119 | MP0005220_abnormal_exocrine_pancreas | 0.90049512 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.89922088 |
| 121 | MP0001851_eye_inflammation | 0.88444782 |
| 122 | MP0002933_joint_inflammation | 0.88432185 |
| 123 | MP0009053_abnormal_anal_canal | 0.88046199 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.87078075 |
| 125 | MP0009046_muscle_twitch | 0.87029232 |
| 126 | MP0002160_abnormal_reproductive_system | 0.86400202 |
| 127 | MP0002733_abnormal_thermal_nociception | 0.86316212 |
| 128 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85479495 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.83020454 |
| 130 | MP0000516_abnormal_urinary_system | 0.82755173 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.82755173 |
| 132 | MP0005076_abnormal_cell_differentiation | 0.82510177 |
| 133 | MP0003828_pulmonary_edema | 0.82144178 |
| 134 | MP0001835_abnormal_antigen_presentation | 0.81879472 |
| 135 | MP0009840_abnormal_foam_cell | 0.81214444 |
| 136 | MP0003763_abnormal_thymus_physiology | 0.80303825 |
| 137 | MP0003252_abnormal_bile_duct | 0.79795298 |
| 138 | MP0010329_abnormal_lipoprotein_level | 0.79594171 |
| 139 | MP0002111_abnormal_tail_morphology | 0.79529913 |
| 140 | MP0003633_abnormal_nervous_system | 0.78510870 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.77712500 |
| 142 | MP0005389_reproductive_system_phenotype | 0.77565163 |
| 143 | MP0001873_stomach_inflammation | 0.77496502 |
| 144 | MP0003122_maternal_imprinting | 0.77315970 |
| 145 | MP0000920_abnormal_myelination | 0.77235838 |
| 146 | MP0003279_aneurysm | 0.75276938 |
| 147 | MP0002735_abnormal_chemical_nociception | 0.75258887 |
| 148 | MP0000678_abnormal_parathyroid_gland | 0.75028032 |
| 149 | MP0000685_abnormal_immune_system | 0.74738259 |
| 150 | MP0005671_abnormal_response_to | 0.74010526 |
| 151 | MP0005408_hypopigmentation | 0.73945024 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.73649911 |
| 153 | MP0005058_abnormal_lysosome_morphology | 0.73357899 |
| 154 | MP0005384_cellular_phenotype | 0.73243829 |
| 155 | MP0001970_abnormal_pain_threshold | 0.73096135 |
| 156 | MP0002063_abnormal_learning/memory/cond | 0.72905888 |
| 157 | MP0004133_heterotaxia | 0.72883160 |
| 158 | MP0003329_amyloid_beta_deposits | 0.72183096 |
| 159 | MP0002693_abnormal_pancreas_physiology | 0.72079750 |
| 160 | MP0008872_abnormal_physiological_respon | 0.72009039 |
| 161 | MP0000013_abnormal_adipose_tissue | 0.71431903 |
| 162 | MP0003448_altered_tumor_morphology | 0.70825005 |
| 163 | MP0005390_skeleton_phenotype | 0.67937970 |
| 164 | MP0009763_increased_sensitivity_to | 0.67402458 |
| 165 | MP0001764_abnormal_homeostasis | 0.67328992 |
| 166 | MP0002938_white_spotting | 0.67308523 |
| 167 | MP0005535_abnormal_body_temperature | 0.67185690 |
| 168 | MP0008569_lethality_at_weaning | 0.66541552 |
| 169 | MP0004130_abnormal_muscle_cell | 0.66398589 |
| 170 | MP0001663_abnormal_digestive_system | 0.66236343 |
| 171 | MP0005621_abnormal_cell_physiology | 0.65975269 |
| 172 | MP0002722_abnormal_immune_system | 0.65734276 |
| 173 | MP0000163_abnormal_cartilage_morphology | 0.65304593 |
| 174 | MP0002398_abnormal_bone_marrow | 0.64413365 |
| 175 | MP0001293_anophthalmia | 0.64195564 |
| 176 | MP0003724_increased_susceptibility_to | 0.62736829 |
| 177 | MP0003890_abnormal_embryonic-extraembry | 0.62599075 |
| 178 | MP0000477_abnormal_intestine_morphology | 0.62328799 |
| 179 | MP0002210_abnormal_sex_determination | 0.62273112 |
| 180 | MP0000689_abnormal_spleen_morphology | 0.62190396 |
| 181 | MP0002429_abnormal_blood_cell | 0.61234603 |
| 182 | MP0003943_abnormal_hepatobiliary_system | 0.61002942 |
| 183 | MP0002113_abnormal_skeleton_development | 0.60561277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.36037619 |
| 2 | T lymphocytopenia (HP:0005403) | 4.36161686 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36074138 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.14988511 |
| 5 | Carpal bone hypoplasia (HP:0001498) | 3.77301695 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.76861225 |
| 7 | Irregular epiphyses (HP:0010582) | 3.62406238 |
| 8 | Myositis (HP:0100614) | 3.59842394 |
| 9 | IgG deficiency (HP:0004315) | 3.44797379 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.41309969 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.39933190 |
| 12 | Thyroiditis (HP:0100646) | 3.35050253 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.34072365 |
| 14 | 11 pairs of ribs (HP:0000878) | 3.32269186 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.30572653 |
| 16 | Degeneration of anterior horn cells (HP:0002398) | 3.30045857 |
| 17 | Abnormality of the anterior horn cell (HP:0006802) | 3.30045857 |
| 18 | Eosinophilia (HP:0001880) | 3.26567844 |
| 19 | Leukocytosis (HP:0001974) | 3.21426447 |
| 20 | Aplastic anemia (HP:0001915) | 3.16950333 |
| 21 | Abnormality of T cells (HP:0002843) | 3.15311082 |
| 22 | Granulocytopenia (HP:0001913) | 3.13058802 |
| 23 | Optic neuritis (HP:0100653) | 3.10860285 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.10860285 |
| 25 | Breast hypoplasia (HP:0003187) | 3.02509702 |
| 26 | Orchitis (HP:0100796) | 3.00306706 |
| 27 | Eczematoid dermatitis (HP:0000976) | 2.99349738 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.97470407 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.96648894 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96104618 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92457693 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92457693 |
| 33 | Flat capital femoral epiphysis (HP:0003370) | 2.90698996 |
| 34 | Vasculitis (HP:0002633) | 2.88621399 |
| 35 | Papilledema (HP:0001085) | 2.85421500 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.84344403 |
| 37 | Cervical subluxation (HP:0003308) | 2.83096725 |
| 38 | Abnormality of the prostate (HP:0008775) | 2.82198828 |
| 39 | Rough bone trabeculation (HP:0100670) | 2.81519196 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.81481385 |
| 41 | Combined immunodeficiency (HP:0005387) | 2.80487490 |
| 42 | Meningitis (HP:0001287) | 2.80272192 |
| 43 | Encephalitis (HP:0002383) | 2.78720354 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.76466421 |
| 45 | Reticulocytopenia (HP:0001896) | 2.76322705 |
| 46 | Trismus (HP:0000211) | 2.74561649 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.73691164 |
| 48 | Vertebral compression fractures (HP:0002953) | 2.72025500 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.71471031 |
| 50 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.71084984 |
| 51 | Metaphyseal cupping (HP:0003021) | 2.69485690 |
| 52 | Selective tooth agenesis (HP:0001592) | 2.68042802 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.67319868 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.66215534 |
| 55 | Hemoptysis (HP:0002105) | 2.64424793 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.57785169 |
| 57 | Abnormal number of erythroid precursors (HP:0012131) | 2.56979396 |
| 58 | Chronic diarrhea (HP:0002028) | 2.55146139 |
| 59 | Beaking of vertebral bodies (HP:0004568) | 2.54731744 |
| 60 | Episodic fever (HP:0001954) | 2.54429428 |
| 61 | Secondary amenorrhea (HP:0000869) | 2.54171683 |
| 62 | Pustule (HP:0200039) | 2.52828828 |
| 63 | Thrombocytosis (HP:0001894) | 2.52428650 |
| 64 | Epiphyseal dysplasia (HP:0002656) | 2.52420392 |
| 65 | Missing ribs (HP:0000921) | 2.52108747 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52051901 |
| 67 | Obstructive lung disease (HP:0006536) | 2.52051901 |
| 68 | Increased IgM level (HP:0003496) | 2.49615961 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.48717978 |
| 70 | Chest pain (HP:0100749) | 2.47660828 |
| 71 | Delayed epiphyseal ossification (HP:0002663) | 2.45770326 |
| 72 | Clumsiness (HP:0002312) | 2.43863797 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.42808477 |
| 74 | Stomach cancer (HP:0012126) | 2.39363800 |
| 75 | Small epiphyses (HP:0010585) | 2.37016516 |
| 76 | Absent speech (HP:0001344) | 2.36194990 |
| 77 | Recurrent viral infections (HP:0004429) | 2.36185353 |
| 78 | Febrile seizures (HP:0002373) | 2.35578356 |
| 79 | Multiple enchondromatosis (HP:0005701) | 2.33975982 |
| 80 | Epistaxis (HP:0000421) | 2.33422600 |
| 81 | Diplopia (HP:0000651) | 2.33289068 |
| 82 | Abnormality of binocular vision (HP:0011514) | 2.33289068 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.33103208 |
| 84 | Poor head control (HP:0002421) | 2.31282997 |
| 85 | Gingival bleeding (HP:0000225) | 2.29715667 |
| 86 | Recurrent skin infections (HP:0001581) | 2.26341596 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.25786455 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.25020013 |
| 89 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.22236121 |
| 90 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.21994540 |
| 91 | Abnormal trabecular bone morphology (HP:0100671) | 2.21468862 |
| 92 | Oral leukoplakia (HP:0002745) | 2.20596319 |
| 93 | Biconcave vertebral bodies (HP:0004586) | 2.20541278 |
| 94 | Flattened epiphyses (HP:0003071) | 2.20195529 |
| 95 | Petechiae (HP:0000967) | 2.20188853 |
| 96 | Microretrognathia (HP:0000308) | 2.19378925 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.18777528 |
| 98 | Joint swelling (HP:0001386) | 2.18094692 |
| 99 | Cleft eyelid (HP:0000625) | 2.18079941 |
| 100 | Lymphopenia (HP:0001888) | 2.18016261 |
| 101 | Atonic seizures (HP:0010819) | 2.16844783 |
| 102 | Genu varum (HP:0002970) | 2.16525344 |
| 103 | Mutism (HP:0002300) | 2.15523987 |
| 104 | Glossoptosis (HP:0000162) | 2.15297155 |
| 105 | B lymphocytopenia (HP:0010976) | 2.14306392 |
| 106 | Patent foramen ovale (HP:0001655) | 2.12176601 |
| 107 | Facial diplegia (HP:0001349) | 2.11575650 |
| 108 | Breech presentation (HP:0001623) | 2.10964890 |
| 109 | Dysostosis multiplex (HP:0000943) | 2.10941981 |
| 110 | Platyspondyly (HP:0000926) | 2.10607072 |
| 111 | Cupped ribs (HP:0000887) | 2.10440332 |
| 112 | Abnormality of the calcaneus (HP:0008364) | 2.10438763 |
| 113 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.09940163 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.09734333 |
| 115 | Irregular vertebral endplates (HP:0003301) | 2.09340673 |
| 116 | Hypoproteinemia (HP:0003075) | 2.09200358 |
| 117 | Patellar aplasia (HP:0006443) | 2.08258503 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 2.04593865 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 2.03405065 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 2.03212063 |
| 121 | Premature ovarian failure (HP:0008209) | 2.02636207 |
| 122 | Toxemia of pregnancy (HP:0100603) | 2.02075017 |
| 123 | Alveolar cell carcinoma (HP:0006519) | 2.01649741 |
| 124 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01465233 |
| 125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01465233 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01465233 |
| 127 | Cerebral hypomyelination (HP:0006808) | 2.01045026 |
| 128 | Recurrent bronchitis (HP:0002837) | 2.00023959 |
| 129 | Increased cerebral lipofuscin (HP:0011813) | 1.99360059 |
| 130 | Keratoconjunctivitis (HP:0001096) | 1.98998431 |
| 131 | Congenital stationary night blindness (HP:0007642) | 1.98600816 |
| 132 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.97648840 |
| 133 | Absent epiphyses (HP:0010577) | 1.97648840 |
| 134 | Metaphyseal dysplasia (HP:0100255) | 1.96738869 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95069560 |
| 136 | Sparse eyelashes (HP:0000653) | 1.94804704 |
| 137 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.94032812 |
| 138 | Macrocytic anemia (HP:0001972) | 1.92998473 |
| 139 | Pulmonary embolism (HP:0002204) | 1.92027471 |
| 140 | Abnormal tarsal ossification (HP:0008369) | 1.90223522 |
| 141 | Vertebral hypoplasia (HP:0008417) | 1.90136537 |
| 142 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.90136537 |
| 143 | Abnormal protein glycosylation (HP:0012346) | 1.90108348 |
| 144 | Abnormal glycosylation (HP:0012345) | 1.90108348 |
| 145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.90108348 |
| 146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.90108348 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89799332 |
| 148 | Abnormal pancreas size (HP:0012094) | 1.87381656 |
| 149 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86798678 |
| 150 | Abnormality of femoral epiphyses (HP:0006499) | 1.86359589 |
| 151 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.86359589 |
| 152 | Abnormality of the acetabulum (HP:0003170) | 1.86279966 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86260065 |
| 154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86260065 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86260065 |
| 156 | Inflammation of the large intestine (HP:0002037) | 1.86176713 |
| 157 | Vertigo (HP:0002321) | 1.85860964 |
| 158 | Colon cancer (HP:0003003) | 1.84875316 |
| 159 | Spinal muscular atrophy (HP:0007269) | 1.83779848 |
| 160 | Pulmonary fibrosis (HP:0002206) | 1.81403115 |
| 161 | Chronic otitis media (HP:0000389) | 1.81248187 |
| 162 | Premature graying of hair (HP:0002216) | 1.79660334 |
| 163 | Bile duct proliferation (HP:0001408) | 1.79557606 |
| 164 | Abnormal biliary tract physiology (HP:0012439) | 1.79557606 |
| 165 | Polyneuropathy (HP:0001271) | 1.79508378 |
| 166 | Parakeratosis (HP:0001036) | 1.79468594 |
| 167 | Gangrene (HP:0100758) | 1.79016542 |
| 168 | Increased CSF protein (HP:0002922) | 1.78711858 |
| 169 | IgM deficiency (HP:0002850) | 1.78315123 |
| 170 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78042107 |
| 171 | Abnormality of the vertebral endplates (HP:0005106) | 1.77668519 |
| 172 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.77640975 |
| 173 | Abnormal foot bone ossification (HP:0010675) | 1.77629472 |
| 174 | Flat acetabular roof (HP:0003180) | 1.76784553 |
| 175 | Micronodular cirrhosis (HP:0001413) | 1.73926559 |
| 176 | Stillbirth (HP:0003826) | 1.73429196 |
| 177 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.73377130 |
| 178 | Slender long bone (HP:0003100) | 1.73208923 |
| 179 | Abnormality of dentin (HP:0010299) | 1.73152466 |
| 180 | Nonimmune hydrops fetalis (HP:0001790) | 1.72775522 |
| 181 | Absent thumb (HP:0009777) | 1.72462923 |
| 182 | Neonatal short-limb short stature (HP:0008921) | 1.71845243 |
| 183 | Pallor (HP:0000980) | 1.71747394 |
| 184 | Hypoplasia of the pons (HP:0012110) | 1.71089992 |
| 185 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.71030732 |
| 186 | Hand muscle atrophy (HP:0009130) | 1.70632305 |
| 187 | Coxa vara (HP:0002812) | 1.69695289 |
| 188 | Abnormality of the umbilical cord (HP:0010881) | 1.69071490 |
| 189 | Abnormal vertebral ossification (HP:0100569) | 1.67524474 |
| 190 | Ankle contracture (HP:0006466) | 1.67184340 |
| 191 | Fused cervical vertebrae (HP:0002949) | 1.66543044 |
| 192 | Spinal cord compression (HP:0002176) | 1.66057908 |
| 193 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.65388225 |
| 194 | Abnormality of the femoral head (HP:0003368) | 1.65022305 |
| 195 | Neoplasm of the pancreas (HP:0002894) | 1.63874381 |
| 196 | Soft skin (HP:0000977) | 1.60015874 |
| 197 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.59580910 |
| 198 | Facial cleft (HP:0002006) | 1.59175024 |
| 199 | Optic nerve coloboma (HP:0000588) | 1.59160271 |
| 200 | Short nail (HP:0001799) | 1.58649796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.11906107 |
| 2 | WEE1 | 3.40787401 |
| 3 | NME2 | 3.40243292 |
| 4 | RIPK4 | 3.38613568 |
| 5 | MAP4K1 | 3.37438053 |
| 6 | EPHA2 | 3.05350327 |
| 7 | EIF2AK1 | 2.88333010 |
| 8 | STK16 | 2.65306332 |
| 9 | TAOK3 | 2.62010980 |
| 10 | PLK4 | 2.49960566 |
| 11 | EIF2AK3 | 2.41505064 |
| 12 | FRK | 2.35562730 |
| 13 | DAPK2 | 2.35137543 |
| 14 | PIM2 | 2.28815797 |
| 15 | BRSK2 | 2.27902657 |
| 16 | FES | 2.22200531 |
| 17 | PASK | 2.19015556 |
| 18 | TNK2 | 2.16375669 |
| 19 | TESK1 | 2.03790605 |
| 20 | RPS6KB2 | 1.98185359 |
| 21 | MAP3K3 | 1.90620094 |
| 22 | TSSK6 | 1.90544538 |
| 23 | BMPR2 | 1.87542724 |
| 24 | SIK3 | 1.86290551 |
| 25 | SYK | 1.79294779 |
| 26 | MAP3K13 | 1.78302870 |
| 27 | STK38L | 1.77784179 |
| 28 | ITK | 1.76352924 |
| 29 | RPS6KA4 | 1.72925752 |
| 30 | IKBKE | 1.71461890 |
| 31 | TEC | 1.69066054 |
| 32 | ACVR1B | 1.62964585 |
| 33 | MAP3K14 | 1.62197652 |
| 34 | CDC7 | 1.56140753 |
| 35 | SRPK1 | 1.52981712 |
| 36 | GRK6 | 1.52422486 |
| 37 | BTK | 1.52126692 |
| 38 | MAP4K2 | 1.51871269 |
| 39 | KIT | 1.50220867 |
| 40 | TESK2 | 1.45593740 |
| 41 | ADRBK2 | 1.45083917 |
| 42 | ZAK | 1.43669589 |
| 43 | TTK | 1.42961206 |
| 44 | BLK | 1.42406669 |
| 45 | TGFBR1 | 1.38452710 |
| 46 | KDR | 1.37692099 |
| 47 | SIK2 | 1.36272075 |
| 48 | PLK1 | 1.34494732 |
| 49 | GRK7 | 1.31476397 |
| 50 | CSF1R | 1.29904883 |
| 51 | JAK1 | 1.29203279 |
| 52 | FLT3 | 1.26999679 |
| 53 | EPHA4 | 1.25736547 |
| 54 | LCK | 1.24880070 |
| 55 | CDK7 | 1.23201956 |
| 56 | AURKB | 1.22721805 |
| 57 | CAMKK2 | 1.22170436 |
| 58 | HCK | 1.20761520 |
| 59 | NEK2 | 1.19121632 |
| 60 | MAPK13 | 1.18630619 |
| 61 | MST4 | 1.16891462 |
| 62 | PRKCQ | 1.15117161 |
| 63 | LYN | 1.14778243 |
| 64 | NEK1 | 1.12985688 |
| 65 | MAP3K8 | 1.12848569 |
| 66 | PAK4 | 1.10900745 |
| 67 | PLK3 | 1.08163408 |
| 68 | CSK | 1.07532217 |
| 69 | PINK1 | 1.05727318 |
| 70 | STK10 | 1.03329690 |
| 71 | VRK1 | 1.03101118 |
| 72 | AKT3 | 1.02852019 |
| 73 | ATR | 1.00235361 |
| 74 | NME1 | 0.99455634 |
| 75 | STK24 | 0.99156428 |
| 76 | PIM1 | 0.96010964 |
| 77 | BRSK1 | 0.93084078 |
| 78 | BMPR1B | 0.92670616 |
| 79 | JAK2 | 0.90931808 |
| 80 | NTRK3 | 0.90140387 |
| 81 | MAPKAPK3 | 0.89721444 |
| 82 | LRRK2 | 0.88777271 |
| 83 | AURKA | 0.87267304 |
| 84 | MAP3K11 | 0.87043068 |
| 85 | DYRK3 | 0.86621967 |
| 86 | PBK | 0.85361726 |
| 87 | IRAK3 | 0.85091194 |
| 88 | PRKG2 | 0.84994417 |
| 89 | PDK1 | 0.84600316 |
| 90 | MYLK | 0.83908156 |
| 91 | BCKDK | 0.82909636 |
| 92 | JAK3 | 0.82743575 |
| 93 | MARK3 | 0.82292243 |
| 94 | CHEK2 | 0.81537282 |
| 95 | BRAF | 0.79530925 |
| 96 | PRKCI | 0.78377172 |
| 97 | CDK4 | 0.78091514 |
| 98 | DDR2 | 0.77756727 |
| 99 | LIMK1 | 0.77664200 |
| 100 | MAP2K2 | 0.77184012 |
| 101 | CAMKK1 | 0.74884951 |
| 102 | ERN1 | 0.74614878 |
| 103 | MAP2K3 | 0.74089605 |
| 104 | FGR | 0.73549695 |
| 105 | MKNK1 | 0.73331571 |
| 106 | PAK1 | 0.71846154 |
| 107 | NUAK1 | 0.71136671 |
| 108 | ARAF | 0.69911684 |
| 109 | IRAK1 | 0.67195488 |
| 110 | CDK19 | 0.66510953 |
| 111 | EPHA3 | 0.66486098 |
| 112 | ZAP70 | 0.66360776 |
| 113 | MAP3K12 | 0.65754524 |
| 114 | TBK1 | 0.65612659 |
| 115 | NEK9 | 0.65085681 |
| 116 | SCYL2 | 0.65049465 |
| 117 | DAPK1 | 0.65020224 |
| 118 | MAP2K6 | 0.64997432 |
| 119 | PRKD2 | 0.64977521 |
| 120 | MAP3K5 | 0.64895240 |
| 121 | INSRR | 0.64008933 |
| 122 | STK3 | 0.63772499 |
| 123 | GRK5 | 0.63038020 |
| 124 | EIF2AK2 | 0.60625423 |
| 125 | CHEK1 | 0.60283615 |
| 126 | CSNK2A1 | 0.59849982 |
| 127 | PRKCE | 0.59114217 |
| 128 | MAPK12 | 0.58487176 |
| 129 | PTK2B | 0.57829796 |
| 130 | PAK6 | 0.57293940 |
| 131 | ILK | 0.56549792 |
| 132 | PRKCH | 0.55856048 |
| 133 | IKBKB | 0.55537558 |
| 134 | MKNK2 | 0.52325333 |
| 135 | EPHB1 | 0.51381228 |
| 136 | PAK3 | 0.51177507 |
| 137 | NLK | 0.50778829 |
| 138 | MET | 0.50515216 |
| 139 | PDK2 | 0.49234984 |
| 140 | TRIM28 | 0.48822976 |
| 141 | ABL1 | 0.48691334 |
| 142 | PHKG1 | 0.47521847 |
| 143 | PHKG2 | 0.47521847 |
| 144 | TLK1 | 0.46765247 |
| 145 | MAPKAPK2 | 0.46425334 |
| 146 | FYN | 0.46307684 |
| 147 | OXSR1 | 0.45404633 |
| 148 | CHUK | 0.44691934 |
| 149 | RPS6KA5 | 0.43276254 |
| 150 | CSNK2A2 | 0.42962760 |
| 151 | CDK8 | 0.42677335 |
| 152 | PDK3 | 0.42005066 |
| 153 | PDK4 | 0.42005066 |
| 154 | MAP3K4 | 0.41001632 |
| 155 | PIK3CG | 0.40125088 |
| 156 | NEK6 | 0.39956730 |
| 157 | TXK | 0.39749471 |
| 158 | ATM | 0.38452691 |
| 159 | TYK2 | 0.37188515 |
| 160 | IGF1R | 0.37178960 |
| 161 | MAP2K1 | 0.36868150 |
| 162 | TGFBR2 | 0.36814049 |
| 163 | MAP3K7 | 0.36363436 |
| 164 | PDPK1 | 0.35951292 |
| 165 | GRK1 | 0.35377205 |
| 166 | PRKD3 | 0.35364746 |
| 167 | MAPK11 | 0.35262343 |
| 168 | MELK | 0.35124527 |
| 169 | PRKCZ | 0.34860584 |
| 170 | CDK2 | 0.34499846 |
| 171 | PAK2 | 0.34275460 |
| 172 | LATS1 | 0.34004553 |
| 173 | FER | 0.33389693 |
| 174 | IRAK4 | 0.33344145 |
| 175 | ERBB3 | 0.33182096 |
| 176 | PIK3CA | 0.32166956 |
| 177 | ADRBK1 | 0.31912637 |
| 178 | LATS2 | 0.31591135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.22884347 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.52993937 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.50064079 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.21022987 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.17228089 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.96459853 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.95778749 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.81076235 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.62831673 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.47958175 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44995597 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.35677128 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28980045 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.28296997 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.24567166 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.22739268 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.15000756 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 2.02737257 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99386171 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96960041 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96111823 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89638860 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83390322 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72689497 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.69791999 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59650744 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59635471 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54793238 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.49342884 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.48052614 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38440555 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.35906829 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33960354 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32241586 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27558336 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25595325 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.25435284 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24666227 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21325175 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18031803 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.17855676 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10689336 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.08727629 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08627368 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08163840 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07320788 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 1.07148294 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07052818 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06110687 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04852966 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.03974931 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 1.03428531 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03047060 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.02677635 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02659174 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01707796 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01475510 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97867641 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94971380 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94899857 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93608154 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91210991 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91023681 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90792880 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90131164 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.89413319 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86488931 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86295443 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 0.85700864 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.85566701 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85082908 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 0.83792299 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83135053 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83045313 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82974893 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82223631 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.80872518 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.79261313 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77733374 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.77266730 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77000690 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76492641 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75154771 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74904981 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72757185 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71331329 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70667169 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70243403 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69478209 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68780624 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68427421 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67525127 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67057579 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.65741882 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.64629768 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63827554 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63735642 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63219131 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62608578 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61899829 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61420521 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60435047 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59506904 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59083905 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58958083 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58260116 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.58224091 |
| 108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57486803 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56881126 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56740572 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.56475714 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56445150 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55586406 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.55355629 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54842727 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54446846 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54136088 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53670864 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53117832 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52658553 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.52455698 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.51988758 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50389981 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49513456 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49115089 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47697097 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47222981 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.47150776 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.46856444 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.46756037 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46743818 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44859363 |
| 133 | Allograft rejection_Homo sapiens_hsa05330 | 0.44550641 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43989545 |
| 135 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43323497 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43180911 |
| 137 | Influenza A_Homo sapiens_hsa05164 | 0.43175406 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42996185 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.42085259 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41327582 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41309787 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41042923 |
| 143 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40919700 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40830941 |
| 145 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40729048 |
| 146 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40609812 |
| 147 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40317369 |
| 148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39560539 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39065128 |
| 150 | Taste transduction_Homo sapiens_hsa04742 | 0.38792312 |
| 151 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38771874 |
| 152 | Adherens junction_Homo sapiens_hsa04520 | 0.38617161 |
| 153 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38399918 |
| 154 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37942161 |
| 155 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37790768 |
| 156 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37351048 |
| 157 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37328838 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36686304 |
| 159 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36548946 |
| 160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35599165 |
| 161 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34606858 |
| 162 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33558687 |
| 163 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32770354 |
| 164 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32645325 |
| 165 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32547149 |
| 166 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32153255 |
| 167 | Hepatitis B_Homo sapiens_hsa05161 | 0.31000475 |
| 168 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29050614 |
| 169 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28445292 |
| 170 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26201722 |
| 171 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24799702 |
| 172 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24200867 |
| 173 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23359160 |
| 174 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23075199 |

